Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elderly AML Patients”

178 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 178 results

Testing effectiveness (Phase 2)Ended earlyNCT04914676
What this trial is testing

Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete Remission

Who this might be right for
Acute Myeloid Leukemia
University of Florida 5
Not applicableLooking for participantsNCT07250217
What this trial is testing

Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients

Who this might be right for
Acute Myeloblastic Leukemia
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace 30
Testing effectiveness (Phase 2)Ended earlyNCT02634827
What this trial is testing

Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Gene MutationsFLT3 Tyrosine Kinase Domain Point Mutation+2 more
Mayo Clinic 1
Large-scale testing (Phase 3)Study completedNCT00931138
What this trial is testing

Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2

Who this might be right for
Acute Myeloid Leukemia
Acute Leukemia French Association 420
Testing effectiveness (Phase 2)Study completedNCT00027872
What this trial is testing

Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+18 more
National Cancer Institute (NCI) 125
Testing effectiveness (Phase 2)UnknownNCT04254640
What this trial is testing

Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML

Who this might be right for
Acute Myeloid LeukemiaElderly PatientsNewly Diagnosed
Sun Yat-sen University 34
Large-scale testing (Phase 3)UnknownNCT01633099
What this trial is testing

Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients

Who this might be right for
Untreated Adult Acute Myeloid LeukemiaEffect of DrugsDrug Safety
Jianxiang Wang 46
Testing effectiveness (Phase 2)Study completedNCT00788892
What this trial is testing

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
Jazz Pharmaceuticals 126
Large-scale testing (Phase 3)Study completedNCT00952588
What this trial is testing

Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia
AstraZeneca 74
Early research (Phase 1)Looking for participantsNCT06651866
What this trial is testing

Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Xiamen University 18
Not applicableLooking for participantsNCT05909293
What this trial is testing

Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital with Nanjing Medical University 100
Testing effectiveness (Phase 2)UnknownNCT04541277
What this trial is testing

Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia, in Relapsed or RefractoryAcute Myeloid Leukemia, Elderly, UnfitAcute Myeloid Leukemia With Positive Minimal Residual Disease
Chinese PLA General Hospital 55
Testing effectiveness (Phase 2)Ended earlyNCT00655395
What this trial is testing

Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Viron Therapeutics Inc 25
Testing effectiveness (Phase 2)Study completedNCT00840346
What this trial is testing

Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML)

Who this might be right for
Acute Myeloblastic Leukaemia
PETHEMA Foundation 46
Not applicableLooking for participantsNCT06066242
What this trial is testing

Optimizing Induction Chemotherapy Regimens for ND Elderly AML Patients Who Are Eligible for Intense Chemotherapy

Who this might be right for
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 90
Large-scale testing (Phase 3)Study completedNCT01237808
What this trial is testing

Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation

Who this might be right for
Acute Myeloid Leukemia (AML)
University of Ulm 144
Testing effectiveness (Phase 2)Ended earlyNCT01160354
What this trial is testing

Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous Leukemia
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT02306291
What this trial is testing

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

Who this might be right for
Leukemia, Myeloid, Acute
GlycoMimetics Incorporated 91
Testing effectiveness (Phase 2)Study completedNCT00373529
What this trial is testing

Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)

Who this might be right for
Acute Myelogenous LeukemiaAcute Myeloid Leukemia
Genzyme, a Sanofi Company 116
Not applicableNot Yet RecruitingNCT06946602
What this trial is testing

Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT.

Who this might be right for
AMLElderly
Peking University People's Hospital 307
Load More Results